UK Marketing Authorization Holder Information: It
Post# of 148162
Its interesting in the UK clinical trial info,
https://www.clinicaltrialsregister.eu/ctr-sea...1996-33/GB
they already mention the company that will be doing the packaging/distribution of Leronlimab
On line D.2.1.1.2, it says: that the “Name of the Marketing Authorisation holder,” is:
“SHARP CLINICAL SERVICES (UK) LIMITED.”
Sounds like this may be further along than the company has publically released information.
Read between the lines.